News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Panel To Discuss Roche Holding AG (RHHBF.PK) Arthritis Drug July 29


6/5/2008 8:16:57 AM

LONDON, June 5 (Reuters) - Roche Holding AG's experimental arthritis drug Actemra will be considered for approval by a U.S. Food and Drug Administration panel on July 29. The new drug, which Roche views as a potential blockbuster, will be discussed by the watchdog's Arthritis Advisory Committee, according to the agency's telephone information line.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES